Cost-effectiveness analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for the prevention of RSV illness among infants in Hong Kong
Objectives: Respiratory syncytial virus (RSV) is a leading cause of hospital admissions for acute respiratory infection among infants. A novel RSV prefusion F protein subunit (RSVpreF) vaccine has been recently approved in Hong Kong. The clinical and economic burden of RSV among infants in Hong Kong...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2026-05-01
|
| Serier: | International Journal of Infectious Diseases |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S1201971226001384 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
